HLA‐B*35:01 and Green Tea–Induced Liver Injury

Herbal supplements, and particularly multi‐ingredient products, have become increasingly common causes of acute liver injury. Green tea is a frequent component in implicated products, but its role in liver injury is controversial. The aim of this study was to better characterize the clinical features, outcomes, and pathogenesis of green tea‐associated liver injury.

[1]  R. Fontana,et al.  United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts , 2020, Toxicology reports.

[2]  Winnie Martinez,et al.  National Institute of Diabetes and Digestive and Kidney Diseases , 2020, Definitions.

[3]  E. Björnsson,et al.  Drug-Induced Liver Injury - Types and Phenotypes. , 2019, The New England journal of medicine.

[4]  YU Peng,et al.  HLA‐B*35:01 Allele Is a Potential Biomarker for Predicting Polygonum multiflorum–Induced Liver Injury in Humans , 2019, Hepatology.

[5]  J. Sharfstein,et al.  The Opportunity of CBD - Reforming the Law. , 2019, New England Journal of Medicine.

[6]  R. Fontana,et al.  The Contents of Herbal and Dietary Supplements Implicated in Liver Injury in the United States Are Frequently Mislabeled , 2019, Hepatology communications.

[7]  Jiezhun Gu,et al.  The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine. , 2018, Journal of hepatology.

[8]  Joseph M Betz,et al.  The Dietary Supplement Label Database: Recent Developments and Applications. , 2018, The Journal of nutrition.

[9]  Hafiz M.N. Iqbal,et al.  Green tea (Camellia sinensis) and l-theanine: Medicinal values and beneficial applications in humans-A comprehensive review. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  Jian-Min Yuan,et al.  Effect of Green Tea Supplements on Liver Enzyme Elevation: Results from a Randomized Intervention Study in the United States , 2017, Cancer Prevention Research.

[11]  M. Verma,et al.  The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware , 2017, Drug Safety.

[12]  M. Daly,et al.  Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study. , 2017, Gastroenterology.

[13]  J. Serrano,et al.  Liver injury from herbal and dietary supplements , 2017, Hepatology.

[14]  R. Fontana,et al.  Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK® Weight Loss Products: Results from the DILIN Prospective Study , 2016, Drug Safety.

[15]  William M. Lee,et al.  Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study. , 2015, Gastroenterology.

[16]  G. Mazzanti,et al.  Hepatotoxicity of green tea: an update , 2015, Archives of Toxicology.

[17]  H. Barnhart,et al.  Liver injury from herbals and dietary supplements in the U.S. Drug‐Induced Liver Injury Network , 2014, Hepatology.

[18]  William M. Lee,et al.  Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical Associations , 2013, Hepatology.

[19]  B S Weir,et al.  HIBAG—HLA genotype imputation with attribute bagging , 2013, The Pharmacogenomics Journal.

[20]  William M. Lee,et al.  Hepatotoxicity Due to Hydroxycut: A Case Series , 2010, The American Journal of Gastroenterology.

[21]  R. Fontana,et al.  Causality assessment in drug‐induced liver injury using a structured expert opinion process: Comparison to the Roussel‐Uclaf causality assessment method , 2010, Hepatology.

[22]  R. Bhattacharya,et al.  Fulminant hepatic failure after use of the herbal weight-loss supplement exilis. , 2009, Annals of internal medicine.

[23]  M. Daly,et al.  HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin , 2009, Nature Genetics.

[24]  G. Mazzanti,et al.  Hepatotoxicity from green tea: a review of the literature and two unpublished cases , 2009, European Journal of Clinical Pharmacology.

[25]  Joseph K. Lim,et al.  Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements. , 2008, World journal of gastroenterology.

[26]  R. Olsson,et al.  Serious adverse liver reactions associated with herbal weight-loss supplements. , 2007, Journal of hepatology.

[27]  Shinichi Kuriyama,et al.  Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. , 2006, JAMA.

[28]  R. Temple,et al.  Hy's law: predicting serious hepatotoxicity , 2006, Pharmacoepidemiology and drug safety.

[29]  M. Jimenez-saenz,et al.  Acute hepatitis associated with the use of green tea infusions. , 2006, Journal of hepatology.

[30]  P. O'Brien,et al.  Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. , 2006, Free radical biology & medicine.

[31]  H. Bonkovsky.  Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). , 2006, Annals of internal medicine.

[32]  C. McClain,et al.  Diverse antioxidants protect against acetaminophen hepatotoxicity , 2005, Journal of biochemical and molecular toxicology.

[33]  D. Heber,et al.  Catechin Content of 18 Teas and a Green Tea Extract Supplement Correlates With the Antioxidant Capacity , 2003, Nutrition and cancer.

[34]  R. Fontana,et al.  Drug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct , 2013 .

[35]  S. Sang,et al.  Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[36]  R. Fontana,et al.  Drug-Induced Liver Injury Network (DILIN) Prospective Study , 2009, Drug safety.

[37]  G. Mahady,et al.  Safety of Green Tea Extracts , 2008, Drug safety.

[38]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .